Savara (SVRA) Preferred Stock Liabilities (2014 - 2016)

Savara's (SVRA) quarterly Preferred Stock Liabilities came in at $43.9 million in Q4 2016, up 2.04% year-on-year from $43.0 million in Q1 2016, and up 2.04% on a QoQ basis from $43.0 million in Q4 2015.

Savara (SVRA) Preferred Stock Liabilities (2014 - 2016) Analysis & Trends

Savara (SVRA) has 3 years of Preferred Stock Liabilities data on file, last reported at $43.9 million in Q4 2016.

  • On a quarterly basis, Preferred Stock Liabilities rose 2.04% year-over-year to $43.9 million in Q4 2016; TTM through Dec 2016 was $43.9 million, a 2.04% increase from a year earlier, with the FY2016 full-year figure at $43.9 million, up 2.04% from the prior year.
  • Preferred Stock Liabilities for Q4 2016 stood at $43.9 million, up from $43.0 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for SVRA reached as high as $43.9 million in Q4 2016 and fell as low as $20.3 million in Q4 2014.
  • Historically, Preferred Stock Liabilities has averaged $35.7 million across 3 years, with a median of $43.0 million in 2015.
  • Across the five-year window, Preferred Stock Liabilities jumped 112.05% in 2015 and increased 2.04% in 2016, its largest moves.
  • Year by year, Preferred Stock Liabilities stood at $20.3 million in 2014, then jumped by 112.05% to $43.0 million in 2015, then climbed by 2.04% to $43.9 million in 2016.
  • Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $43.9 million in Q4 2016, $43.0 million in Q4 2015, and $20.3 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Savara 1.24 Bn 1.24 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 43.86 Mn
Dec 31, 2015 42.99 Mn
Dec 31, 2014 20.27 Mn